Roh YS - Search Results

1

Blockade of 11β-hydroxysteroid dehydrogenase type 1 ameliorates metabolic dysfunction-associated steatotic liver disease and fibrosis.

Ma H, Sui GY, Park JS, Wang F, Ma Y, Shin DS, Rustamov N, Jang JS, Chang SI, Lee J, Roh YS. Ma H, et al. Among authors: roh ys. Heliyon. 2024 Oct 18;10(20):e39534. doi: 10.1016/j.heliyon.2024.e39534. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39498052 Free PMC article.

2

Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease.

Lee J, Park JS, Roh YS. Lee J, et al. Among authors: roh ys. Arch Pharm Res. 2019 Nov;42(11):935-946. doi: 10.1007/s12272-019-01178-1. Epub 2019 Sep 30. Arch Pharm Res. 2019. PMID: 31571145 Review.

3

Ginseng Saponin Enriched in Rh1 and Rg2 Ameliorates Nonalcoholic Fatty Liver Disease by Inhibiting Inflammasome Activation.

Wang F, Park JS, Ma Y, Ma H, Lee YJ, Lee GR, Yoo HS, Hong JT, Roh YS. Wang F, et al. Among authors: roh ys. Nutrients. 2021 Mar 5;13(3):856. doi: 10.3390/nu13030856. Nutrients. 2021. PMID: 33807927 Free PMC article.

4

Ubiquitin pathways regulate the pathogenesis of chronic liver disease.

Park JS, Ma H, Roh YS. Park JS, et al. Among authors: roh ys. Biochem Pharmacol. 2021 Nov;193:114764. doi: 10.1016/j.bcp.2021.114764. Epub 2021 Sep 13. Biochem Pharmacol. 2021. PMID: 34529948 Review.

5

Mitochondrial Control in Inflammatory Gastrointestinal Diseases.

Sui GY, Wang F, Lee J, Roh YS. Sui GY, et al. Among authors: roh ys. Int J Mol Sci. 2022 Nov 28;23(23):14890. doi: 10.3390/ijms232314890. Int J Mol Sci. 2022. PMID: 36499214 Free PMC article. Review.

6

Cocaine-derived hippuric acid activates mtDNA-STING signaling in alcoholic liver disease: Implications for alcohol and cocaine co-abuse.

Ma H, Lee GR, Park JS, Lee J, Wang F, Ma Y, Sui GY, Rustamov N, Kim SH, Jung YS, Yoo HS, Han SB, Hong JT, Yun J, Roh YS. Ma H, et al. Among authors: roh ys. Cell Biol Toxicol. 2024 Aug 16;40(1):71. doi: 10.1007/s10565-024-09901-5. Cell Biol Toxicol. 2024. PMID: 39147926 Free PMC article.

7

Mitochondrial connection to ginsenosides.

Wang F, Roh YS. Wang F, et al. Among authors: roh ys. Arch Pharm Res. 2020 Oct;43(10):1031-1045. doi: 10.1007/s12272-020-01279-2. Epub 2020 Oct 28. Arch Pharm Res. 2020. PMID: 33113096 Review.

8

Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease.

Ma Y, Lee G, Heo SY, Roh YS. Ma Y, et al. Among authors: roh ys. Antioxidants (Basel). 2021 Dec 30;11(1):91. doi: 10.3390/antiox11010091. Antioxidants (Basel). 2021. PMID: 35052595 Free PMC article. Review.

9

Fermented Korean Red Ginseng Extract Enriched in Rd and Rg3 Protects against Non-Alcoholic Fatty Liver Disease through Regulation of mTORC1.

Choi SY, Park JS, Shon CH, Lee CY, Ryu JM, Son DJ, Hwang BY, Yoo HS, Cho YC, Lee J, Kim JW, Roh YS. Choi SY, et al. Among authors: roh ys. Nutrients. 2019 Dec 4;11(12):2963. doi: 10.3390/nu11122963. Nutrients. 2019. PMID: 31817227 Free PMC article.

10

Centipeda minima Extract Inhibits Inflammation and Cell Proliferation by Regulating JAK/STAT Signaling in Macrophages and Keratinocytes.

Ma Y, Kim BH, Yun SK, Roh YS. Ma Y, et al. Among authors: roh ys. Molecules. 2023 Feb 11;28(4):1723. doi: 10.3390/molecules28041723. Molecules. 2023. PMID: 36838711 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters